Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Pere Puigserver, Ph.D., Dana-Farber Cancer Institute

Caption: Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow aging.

Credit: Dana-Farber Cancer Institute

Usage Restrictions: None

Related news release: Study reveals how cancer drug causes diabetic-like state